First Time Loading...

Andon Health Co Ltd
SZSE:002432

Watchlist Manager
Andon Health Co Ltd Logo
Andon Health Co Ltd
SZSE:002432
Watchlist
Price: 42.27 CNY 0.79% Market Closed
Updated: Apr 27, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

22.1B
-0.1%
Assets
Growth Rates:
1 Year
+8%
3 Years
+747%
5 Years
+1 100%
7 Years
+1 240%
10 Years
+2 515%
2.1B
-0.6%
Liabilities
Growth Rates:
1 Year
-2%
3 Years
+213%
5 Years
+436%
7 Years
+1 121%
10 Years
+2 425%
20B
0%
Equity
Growth Rates:
1 Year
+9%
3 Years
+933%
5 Years
+1 280%
7 Years
+1 254%
10 Years
+2 525%

Balance Sheet Decomposition
Andon Health Co Ltd

22.1B
Assets
2.1B
Liabilities
22.1B
Assets
2.1B
Liabilities
Current Assets 10.1B
Cash & Short-Term Investments 9.6B
Receivables 160.2m
Other Current Assets 370m
Non-Current Assets 12B
Long-Term Investments 11.4B
PP&E 396.8m
Intangibles 129.4m
Other Non-Current Assets 84.5m
Current Liabilities 482.4m
Accounts Payable 81.8m
Accrued Liabilities 37.4m
Short-Term Debt 260m
Other Current Liabilities 103.2m
Non-Current Liabilities 1.6B
Long-Term Debt 20m
Other Non-Current Liabilities 1.6B

Balance Sheet
Andon Health Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
339
118
122
755
655
438
331
914
541
5 403
Cash
0
0
0
0
0
0
0
0
541
5 397
Cash Equivalents
338
118
122
754
655
438
331
914
0
6
Short-Term Investments
0
0
0
37
0
3
401
289
448
6 316
Total Receivables
116
135
96
194
132
196
125
166
782
461
Accounts Receivables
108
84
81
102
104
91
100
142
589
392
Other Receivables
8
51
15
92
28
105
25
24
193
69
Inventory
204
273
270
234
204
239
197
281
628
698
Other Current Assets
16
171
7
274
149
15
10
25
460
317
Total Current Assets
675
697
495
1 493
1 140
892
1 064
1 675
2 859
13 195
PP&E Net
180
193
219
218
209
223
209
193
255
366
PP&E Gross
180
193
219
218
209
223
209
193
255
366
Accumulated Depreciation
20
29
44
65
83
106
125
156
194
230
Intangible Assets
70
79
81
134
153
178
170
155
172
154
Goodwill
0
0
0
489
523
437
359
243
219
94
Long-Term Investments
0
25
14
6
56
79
42
119
316
7 866
Other Long-Term Assets
9
8
11
16
18
99
96
73
110
56
Other Assets
0
0
0
489
523
437
359
243
219
94
Total Assets
934
N/A
1 002
+7%
820
-18%
2 356
+187%
2 098
-11%
1 908
-9%
1 940
+2%
2 459
+27%
3 930
+60%
21 731
+453%
Liabilities
Accounts Payable
55
59
33
32
52
78
79
139
191
312
Accrued Liabilities
15
18
21
31
32
28
33
50
82
101
Short-Term Debt
97
123
49
140
70
150
0
168
208
260
Current Portion of Long-Term Debt
0
0
0
1
289
0
1
75
137
28
Other Current Liabilities
20
41
102
291
273
48
27
66
420
98
Total Current Liabilities
186
241
205
495
716
304
140
499
1 038
799
Long-Term Debt
0
0
0
307
0
73
198
128
34
30
Deferred Income Tax
0
0
0
7
6
4
2
0
0
859
Minority Interest
0
0
0
0
0
16
64
62
36
470
Other Liabilities
0
3
6
6
7
2
2
9
22
18
Total Liabilities
187
N/A
244
+31%
211
-13%
815
+286%
729
-11%
366
-50%
278
-24%
574
+107%
1 058
+84%
2 176
+106%
Equity
Common Stock
372
372
372
433
433
433
433
433
481
485
Retained Earnings
77
88
71
56
222
209
104
138
1 019
16 730
Additional Paid In Capital
300
301
307
1 160
1 161
1 299
1 306
1 308
1 626
1 815
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
3
40
Treasury Stock
0
0
0
0
0
0
0
0
200
107
Other Equity
1
1
1
6
3
21
28
6
58
672
Total Equity
748
N/A
759
+1%
609
-20%
1 542
+153%
1 369
-11%
1 543
+13%
1 663
+8%
1 885
+13%
2 873
+52%
19 554
+581%
Total Liabilities & Equity
934
N/A
1 002
+7%
820
-18%
2 356
+187%
2 098
-11%
1 908
-9%
1 940
+2%
2 459
+27%
3 930
+60%
21 731
+453%
Shares Outstanding
Common Shares Outstanding
372
372
372
433
433
433
433
433
456
471

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.